Clicky

Viva Biotech Holdings(VB0)

Description: Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions. It also offers PROTAC/molecular glue services, including protein preparation and ternary complex structure determination, screening for molecule glues and novel E3 ligase ligands, PROTAC ternary complex kinetics, PROTAC degradation assays and ternary complex assays, PROTAC molecule design and synthesis, ADME & PK/PD studies of PROTAC molecules, and computer aided PROTAC design solutions; and XDC platforms, such as XDC conjugation and quality study, XDC chemistry research and development, and XDC functional studies. In addition, the company offers contract development and manufacturing services comprising integrated services for small molecule active pharmaceutical ingredients, formulation development and production services, and pharmaceutical analysis services, as well as CMC filing, global filing registration support, and other services. Further, it provides laboratory rental, and project management and bidding services, as well as sells compounds. The company was incorporated in 2008 and is headquartered in Shanghai, China.


Keywords: Biotechnology Project Management Pharmacology Drug Discovery Active Pharmaceutical Ingredients Antibody Manufacturing Services Medicinal Chemistry Laboratory Techniques Pharmacokinetics Assay Drug Design Chemistry Services Chemical Biology Computer Aided Drug Design Services Pharmaceutical Customers Structure Based Drug Discovery Services Discovery Biology Services Offers Chemical Technology Platforms

Home Page: www.vivabiotech.com.cn

No.735, Ziping Road
Shanghai, 201318
China
Phone: 86 21 6089 3288


Officers

Name Title
Dr. Chen Cheney Mao Ph.D. Chairman & CEO
Mr. Ying Wu M.B.A. Executive VP & Executive Director
Dr. Delin Ren Ph.D. Executive Director
Mr. Wei Xiong Chief Financial Officer
Mr. Xueheng Cheng Ph.D. Chief Technology Officer
Dr. Zhixiong Ye Ph.D. Chief Scientific Officer
Mr. Han Dai Ph.D. Chief Innovation Officer & Head of Viva BioInnovator
Mr. Jianhua Cai Ph.D. Senior Vice President
Jianguo Ma Ph.D. Senior VP & President of Shanghai Langhua Pharmaceutical
Mr. Xianyong Bu Ph.D. CBO & EVP of Viva Biotech (Shanghai)

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.4675
Price-to-Sales TTM: 0.1167
IPO Date:
Fiscal Year End: December
Full Time Employees: 2043
Back to stocks